GlassScriptPhysician profile
Jeremy D Johnson
NPI 1376191569
$4,847.83
in general payments reported to CMS, 2019-2025
40 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $995 · 2022: $1,126 · 2023: $1,266 · 2024: $871 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $778.37 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $710.10 | 2021-2025 | Synjardy, Jardiance, Tradjenta |
| Novo Nordisk INC | $483.29 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $348.38 | 2021-2025 | Farxiga, Airsupra, Fasenra |
| Pfizer INC. | $267.89 | 2021-2025 | |
| Amgen INC. | $258.88 | 2021-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $244.36 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Esperion Therapeutics, INC. | $237.88 | 2021-2025 | Nexletol |
| Astellas Pharma US INC | $119.67 | 2021-2024 | Veozah, Myrbetriq |
| Seqirus USA INC | $117.75 | 2022-2025 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Biohaven Pharmaceuticals, INC. | $101.98 | 2021 | |
| Janssen Pharmaceuticals, INC | $98.38 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $97.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.21 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $85.15 | 2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.